FusionGDB Logo

Home

Download

Statistics

Examples

Help

Contact
Center for Computational Systems Medicine
leaf

Fusion Gene Summary

leaf

Fusion Gene ORF analysis

leaf

Fusion Genomic Features

leaf

Fusion Protein Features

leaf

Fusion Gene Sequence

leaf

Fusion Gene PPI analysis

leaf

Related Drugs

leaf

Related Diseases

Fusion gene:EEF2-SMARCA4 (FusionGDB2 ID:25227)

Fusion Gene Summary for EEF2-SMARCA4

check button Fusion gene summary
Fusion gene informationFusion gene name: EEF2-SMARCA4
Fusion gene ID: 25227
HgeneTgene
Gene symbol

EEF2

SMARCA4

Gene ID

1938

6597

Gene nameeukaryotic translation elongation factor 2SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4
SynonymsEEF-2|EF-2|EF2|SCA26BAF190|BAF190A|BRG1|CSS4|MRD16|RTPS2|SNF2|SNF2-beta|SNF2L4|SNF2LB|SWI2|hSNF2b
Cytomap

19p13.3

19p13.2

Type of geneprotein-codingprotein-coding
Descriptionelongation factor 2epididymis secretory sperm binding proteinpolypeptidyl-tRNA translocasetranscription activator BRG1ATP-dependent helicase SMARCA4BRG1-associated factor 190ABRM/SWI2-related gene 1SNF2-like 4brahma protein-like 1global transcription activator homologous sequencehomeotic gene regulatormitotic growth and transcription a
Modification date2020031320200315
UniProtAcc

P13639

.
Ensembl transtripts involved in fusion geneENST00000309311, ENST00000600720, 
ENST00000358026, ENST00000344626, 
ENST00000429416, ENST00000541122, 
ENST00000589677, ENST00000444061, 
ENST00000590574, ENST00000413806, 
ENST00000450717, ENST00000538456, 
Fusion gene scores* DoF score44 X 37 X 16=2604820 X 28 X 15=8400
# samples 5632
** MAII scorelog2(56/26048*10)=-5.53960196732128
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0		log2(32/8400*10)=-4.71424551766612
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Context

PubMed: EEF2 [Title/Abstract] AND SMARCA4 [Title/Abstract] AND fusion [Title/Abstract]

Most frequent breakpointEEF2(3982805)-SMARCA4(11151983), # samples:1
Anticipated loss of major functional domain due to fusion event.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID
TgeneSMARCA4

GO:0006337

nucleosome disassembly

8895581

TgeneSMARCA4

GO:0006338

chromatin remodeling

10943845|11726552

TgeneSMARCA4

GO:0045892

negative regulation of transcription, DNA-templated

12065415

TgeneSMARCA4

GO:0045944

positive regulation of transcription by RNA polymerase II

15774904|17938176

TgeneSMARCA4

GO:0051091

positive regulation of DNA-binding transcription factor activity

11950834|17938176

TgeneSMARCA4

GO:1902661

positive regulation of glucose mediated signaling pathway

22368283


check buttonFusion gene breakpoints across EEF2 (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.

check buttonFusion gene breakpoints across SMARCA4 (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.

check button Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0)
* All genome coordinats were lifted-over on hg19.
* Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser.
SourceDiseaseSampleHgeneHchrHbpHstrandTgeneTchrTbpTstrand
ChimerDB4Non-CancerTCGA-K1-A3PO-11AEEF2chr19

3982805

-SMARCA4chr19

11151983

+


Top

Fusion Gene ORF analysis for EEF2-SMARCA4

check button Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure.
* Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser.
ORFHenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrand
In-frameENST00000309311ENST00000358026EEF2chr19

3982805

-SMARCA4chr19

11151983

+
In-frameENST00000309311ENST00000344626EEF2chr19

3982805

-SMARCA4chr19

11151983

+
In-frameENST00000309311ENST00000429416EEF2chr19

3982805

-SMARCA4chr19

11151983

+
In-frameENST00000309311ENST00000541122EEF2chr19

3982805

-SMARCA4chr19

11151983

+
In-frameENST00000309311ENST00000589677EEF2chr19

3982805

-SMARCA4chr19

11151983

+
In-frameENST00000309311ENST00000444061EEF2chr19

3982805

-SMARCA4chr19

11151983

+
In-frameENST00000309311ENST00000590574EEF2chr19

3982805

-SMARCA4chr19

11151983

+
In-frameENST00000309311ENST00000413806EEF2chr19

3982805

-SMARCA4chr19

11151983

+
In-frameENST00000309311ENST00000450717EEF2chr19

3982805

-SMARCA4chr19

11151983

+
5CDS-3UTRENST00000309311ENST00000538456EEF2chr19

3982805

-SMARCA4chr19

11151983

+
intron-3CDSENST00000600720ENST00000358026EEF2chr19

3982805

-SMARCA4chr19

11151983

+
intron-3CDSENST00000600720ENST00000344626EEF2chr19

3982805

-SMARCA4chr19

11151983

+
intron-3CDSENST00000600720ENST00000429416EEF2chr19

3982805

-SMARCA4chr19

11151983

+
intron-3CDSENST00000600720ENST00000541122EEF2chr19

3982805

-SMARCA4chr19

11151983

+
intron-3CDSENST00000600720ENST00000589677EEF2chr19

3982805

-SMARCA4chr19

11151983

+
intron-3CDSENST00000600720ENST00000444061EEF2chr19

3982805

-SMARCA4chr19

11151983

+
intron-3CDSENST00000600720ENST00000590574EEF2chr19

3982805

-SMARCA4chr19

11151983

+
intron-3CDSENST00000600720ENST00000413806EEF2chr19

3982805

-SMARCA4chr19

11151983

+
intron-3CDSENST00000600720ENST00000450717EEF2chr19

3982805

-SMARCA4chr19

11151983

+
intron-3UTRENST00000600720ENST00000538456EEF2chr19

3982805

-SMARCA4chr19

11151983

+

check buttonORFfinder result based on the fusion transcript sequence of in-frame fusion genes.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)		BP loci
(transcript)		Predicted start
(transcript)		Predicted stop
(transcript)		Seq length
(amino acids)
ENST00000309311EEF2chr193982805-ENST00000358026SMARCA4chr1911151983+1941701891474461
ENST00000309311EEF2chr193982805-ENST00000344626SMARCA4chr1911151983+1718701891474461
ENST00000309311EEF2chr193982805-ENST00000429416SMARCA4chr1911151983+1941701891474461
ENST00000309311EEF2chr193982805-ENST00000541122SMARCA4chr1911151983+14747014781473332
ENST00000309311EEF2chr193982805-ENST00000589677SMARCA4chr1911151983+14717014781470331
ENST00000309311EEF2chr193982805-ENST00000444061SMARCA4chr1911151983+1472701891471461
ENST00000309311EEF2chr193982805-ENST00000590574SMARCA4chr1911151983+1475701891474462
ENST00000309311EEF2chr193982805-ENST00000413806SMARCA4chr1911151983+19407014781473331
ENST00000309311EEF2chr193982805-ENST00000450717SMARCA4chr1911151983+19377014781470330

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000309311ENST00000358026EEF2chr193982805-SMARCA4chr1911151983+0.0043411850.9956589
ENST00000309311ENST00000344626EEF2chr193982805-SMARCA4chr1911151983+0.0050868620.9949131
ENST00000309311ENST00000429416EEF2chr193982805-SMARCA4chr1911151983+0.0043411850.9956589
ENST00000309311ENST00000541122EEF2chr193982805-SMARCA4chr1911151983+0.0144194580.9855805
ENST00000309311ENST00000589677EEF2chr193982805-SMARCA4chr1911151983+0.0160319280.983968
ENST00000309311ENST00000444061EEF2chr193982805-SMARCA4chr1911151983+0.0040272610.9959727
ENST00000309311ENST00000590574EEF2chr193982805-SMARCA4chr1911151983+0.0037268990.99627316
ENST00000309311ENST00000413806EEF2chr193982805-SMARCA4chr1911151983+0.0258279850.97417206
ENST00000309311ENST00000450717EEF2chr193982805-SMARCA4chr1911151983+0.0275610650.9724389

Top

Fusion Genomic Features for EEF2-SMARCA4


check buttonFusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints.
HgeneHchrHbpHstrandTgeneTchrTbpTstrand1-pp (fusion gene breakpoint)
EEF2chr193982804-SMARCA4chr1911151982+7.10E-070.9999993
EEF2chr193982804-SMARCA4chr1911151982+7.10E-070.9999993

check buttonDistribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page.

check buttonDistribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page.

Top

Fusion Protein Features for EEF2-SMARCA4


check button Go to

FGviewer for the breakpoints of chr19:3982805-chr19:11151983

.
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
FGviewer

check buttonMain function of each fusion partner protein. (from UniProt)
HgeneTgene
EEF2

P13639

.
FUNCTION: Catalyzes the GTP-dependent ribosomal translocation step during translation elongation. During this step, the ribosome changes from the pre-translocational (PRE) to the post-translocational (POST) state as the newly formed A-site-bound peptidyl-tRNA and P-site-bound deacylated tRNA move to the P and E sites, respectively. Catalyzes the coordinated movement of the two tRNA molecules, the mRNA and conformational changes in the ribosome.FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at

download page


* Minus value of BPloci means that the break pointn is located before the CDS.
- In-frame and retained protein feature among the 13 regional features.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note
HgeneEEF2chr19:3982805chr19:11151983ENST00000309311-415104_108204.0859.0Nucleotide bindingGTP
HgeneEEF2chr19:3982805chr19:11151983ENST00000309311-415158_161204.0859.0Nucleotide bindingGTP
HgeneEEF2chr19:3982805chr19:11151983ENST00000309311-41526_33204.0859.0Nucleotide bindingGTP
TgeneSMARCA4chr19:3982805chr19:11151983ENST0000034462628351571_15841390.01648.0Compositional biasNote=Poly-Glu
TgeneSMARCA4chr19:3982805chr19:11151983ENST000004138060331360_13640.01618.0Compositional biasNote=Poly-Glu
TgeneSMARCA4chr19:3982805chr19:11151983ENST000004138060331571_15840.01618.0Compositional biasNote=Poly-Glu
TgeneSMARCA4chr19:3982805chr19:11151983ENST00000413806033578_5880.01618.0Compositional biasNote=Poly-Lys
TgeneSMARCA4chr19:3982805chr19:11151983ENST00000413806033663_6720.01618.0Compositional biasNote=Poly-Glu
TgeneSMARCA4chr19:3982805chr19:11151983ENST0000042941629361571_15841390.01648.0Compositional biasNote=Poly-Glu
TgeneSMARCA4chr19:3982805chr19:11151983ENST0000044406128351360_13641357.01614.0Compositional biasNote=Poly-Glu
TgeneSMARCA4chr19:3982805chr19:11151983ENST0000044406128351571_15841357.01614.0Compositional biasNote=Poly-Glu
TgeneSMARCA4chr19:3982805chr19:11151983ENST000004507170331360_13640.01617.0Compositional biasNote=Poly-Glu
TgeneSMARCA4chr19:3982805chr19:11151983ENST000004507170331571_15840.01617.0Compositional biasNote=Poly-Glu
TgeneSMARCA4chr19:3982805chr19:11151983ENST00000450717033578_5880.01617.0Compositional biasNote=Poly-Lys
TgeneSMARCA4chr19:3982805chr19:11151983ENST00000450717033663_6720.01617.0Compositional biasNote=Poly-Glu
TgeneSMARCA4chr19:3982805chr19:11151983ENST000005411220351360_136401618.0Compositional biasNote=Poly-Glu
TgeneSMARCA4chr19:3982805chr19:11151983ENST000005411220351571_158401618.0Compositional biasNote=Poly-Glu
TgeneSMARCA4chr19:3982805chr19:11151983ENST00000541122035578_58801618.0Compositional biasNote=Poly-Lys
TgeneSMARCA4chr19:3982805chr19:11151983ENST00000541122035663_67201618.0Compositional biasNote=Poly-Glu
TgeneSMARCA4chr19:3982805chr19:11151983ENST000005896770351360_136401617.0Compositional biasNote=Poly-Glu
TgeneSMARCA4chr19:3982805chr19:11151983ENST000005896770351571_158401617.0Compositional biasNote=Poly-Glu
TgeneSMARCA4chr19:3982805chr19:11151983ENST00000589677035578_58801617.0Compositional biasNote=Poly-Lys
TgeneSMARCA4chr19:3982805chr19:11151983ENST00000589677035663_67201617.0Compositional biasNote=Poly-Glu
TgeneSMARCA4chr19:3982805chr19:11151983ENST0000059057427341360_13641357.01615.0Compositional biasNote=Poly-Glu
TgeneSMARCA4chr19:3982805chr19:11151983ENST0000059057427341571_15841357.01615.0Compositional biasNote=Poly-Glu
TgeneSMARCA4chr19:3982805chr19:11151983ENST0000034462628351477_15471390.01648.0DomainBromo
TgeneSMARCA4chr19:3982805chr19:11151983ENST000004138060331084_12460.01618.0DomainHelicase C-terminal
TgeneSMARCA4chr19:3982805chr19:11151983ENST000004138060331477_15470.01618.0DomainBromo
TgeneSMARCA4chr19:3982805chr19:11151983ENST00000413806033171_2060.01618.0DomainQLQ
TgeneSMARCA4chr19:3982805chr19:11151983ENST00000413806033460_5320.01618.0DomainHSA
TgeneSMARCA4chr19:3982805chr19:11151983ENST00000413806033766_9310.01618.0DomainHelicase ATP-binding
TgeneSMARCA4chr19:3982805chr19:11151983ENST0000042941629361477_15471390.01648.0DomainBromo
TgeneSMARCA4chr19:3982805chr19:11151983ENST0000044406128351477_15471357.01614.0DomainBromo
TgeneSMARCA4chr19:3982805chr19:11151983ENST000004507170331084_12460.01617.0DomainHelicase C-terminal
TgeneSMARCA4chr19:3982805chr19:11151983ENST000004507170331477_15470.01617.0DomainBromo
TgeneSMARCA4chr19:3982805chr19:11151983ENST00000450717033171_2060.01617.0DomainQLQ
TgeneSMARCA4chr19:3982805chr19:11151983ENST00000450717033460_5320.01617.0DomainHSA
TgeneSMARCA4chr19:3982805chr19:11151983ENST00000450717033766_9310.01617.0DomainHelicase ATP-binding
TgeneSMARCA4chr19:3982805chr19:11151983ENST000005411220351084_124601618.0DomainHelicase C-terminal
TgeneSMARCA4chr19:3982805chr19:11151983ENST000005411220351477_154701618.0DomainBromo
TgeneSMARCA4chr19:3982805chr19:11151983ENST00000541122035171_20601618.0DomainQLQ
TgeneSMARCA4chr19:3982805chr19:11151983ENST00000541122035460_53201618.0DomainHSA
TgeneSMARCA4chr19:3982805chr19:11151983ENST00000541122035766_93101618.0DomainHelicase ATP-binding
TgeneSMARCA4chr19:3982805chr19:11151983ENST000005896770351084_124601617.0DomainHelicase C-terminal
TgeneSMARCA4chr19:3982805chr19:11151983ENST000005896770351477_154701617.0DomainBromo
TgeneSMARCA4chr19:3982805chr19:11151983ENST00000589677035171_20601617.0DomainQLQ
TgeneSMARCA4chr19:3982805chr19:11151983ENST00000589677035460_53201617.0DomainHSA
TgeneSMARCA4chr19:3982805chr19:11151983ENST00000589677035766_93101617.0DomainHelicase ATP-binding
TgeneSMARCA4chr19:3982805chr19:11151983ENST0000059057427341477_15471357.01615.0DomainBromo
TgeneSMARCA4chr19:3982805chr19:11151983ENST00000413806033881_8840.01618.0MotifNote=DEGH box
TgeneSMARCA4chr19:3982805chr19:11151983ENST00000450717033881_8840.01617.0MotifNote=DEGH box
TgeneSMARCA4chr19:3982805chr19:11151983ENST00000541122035881_88401618.0MotifNote=DEGH box
TgeneSMARCA4chr19:3982805chr19:11151983ENST00000589677035881_88401617.0MotifNote=DEGH box
TgeneSMARCA4chr19:3982805chr19:11151983ENST00000413806033779_7860.01618.0Nucleotide bindingATP
TgeneSMARCA4chr19:3982805chr19:11151983ENST00000450717033779_7860.01617.0Nucleotide bindingATP
TgeneSMARCA4chr19:3982805chr19:11151983ENST00000541122035779_78601618.0Nucleotide bindingATP
TgeneSMARCA4chr19:3982805chr19:11151983ENST00000589677035779_78601617.0Nucleotide bindingATP
TgeneSMARCA4chr19:3982805chr19:11151983ENST00000413806033462_7280.01618.0RegionRNA-binding region which is sufficient for binding to lncRNA Evf2
TgeneSMARCA4chr19:3982805chr19:11151983ENST00000450717033462_7280.01617.0RegionRNA-binding region which is sufficient for binding to lncRNA Evf2
TgeneSMARCA4chr19:3982805chr19:11151983ENST00000541122035462_72801618.0RegionRNA-binding region which is sufficient for binding to lncRNA Evf2
TgeneSMARCA4chr19:3982805chr19:11151983ENST00000589677035462_72801617.0RegionRNA-binding region which is sufficient for binding to lncRNA Evf2

- In-frame and not-retained protein feature among the 13 regional features.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note
HgeneEEF2chr19:3982805chr19:11151983ENST00000309311-41517_362204.0859.0Domaintr-type G
TgeneSMARCA4chr19:3982805chr19:11151983ENST0000034462628351360_13641390.01648.0Compositional biasNote=Poly-Glu
TgeneSMARCA4chr19:3982805chr19:11151983ENST000003446262835578_5881390.01648.0Compositional biasNote=Poly-Lys
TgeneSMARCA4chr19:3982805chr19:11151983ENST000003446262835663_6721390.01648.0Compositional biasNote=Poly-Glu
TgeneSMARCA4chr19:3982805chr19:11151983ENST0000042941629361360_13641390.01648.0Compositional biasNote=Poly-Glu
TgeneSMARCA4chr19:3982805chr19:11151983ENST000004294162936578_5881390.01648.0Compositional biasNote=Poly-Lys
TgeneSMARCA4chr19:3982805chr19:11151983ENST000004294162936663_6721390.01648.0Compositional biasNote=Poly-Glu
TgeneSMARCA4chr19:3982805chr19:11151983ENST000004440612835578_5881357.01614.0Compositional biasNote=Poly-Lys
TgeneSMARCA4chr19:3982805chr19:11151983ENST000004440612835663_6721357.01614.0Compositional biasNote=Poly-Glu
TgeneSMARCA4chr19:3982805chr19:11151983ENST000005905742734578_5881357.01615.0Compositional biasNote=Poly-Lys
TgeneSMARCA4chr19:3982805chr19:11151983ENST000005905742734663_6721357.01615.0Compositional biasNote=Poly-Glu
TgeneSMARCA4chr19:3982805chr19:11151983ENST0000034462628351084_12461390.01648.0DomainHelicase C-terminal
TgeneSMARCA4chr19:3982805chr19:11151983ENST000003446262835171_2061390.01648.0DomainQLQ
TgeneSMARCA4chr19:3982805chr19:11151983ENST000003446262835460_5321390.01648.0DomainHSA
TgeneSMARCA4chr19:3982805chr19:11151983ENST000003446262835766_9311390.01648.0DomainHelicase ATP-binding
TgeneSMARCA4chr19:3982805chr19:11151983ENST0000042941629361084_12461390.01648.0DomainHelicase C-terminal
TgeneSMARCA4chr19:3982805chr19:11151983ENST000004294162936171_2061390.01648.0DomainQLQ
TgeneSMARCA4chr19:3982805chr19:11151983ENST000004294162936460_5321390.01648.0DomainHSA
TgeneSMARCA4chr19:3982805chr19:11151983ENST000004294162936766_9311390.01648.0DomainHelicase ATP-binding
TgeneSMARCA4chr19:3982805chr19:11151983ENST0000044406128351084_12461357.01614.0DomainHelicase C-terminal
TgeneSMARCA4chr19:3982805chr19:11151983ENST000004440612835171_2061357.01614.0DomainQLQ
TgeneSMARCA4chr19:3982805chr19:11151983ENST000004440612835460_5321357.01614.0DomainHSA
TgeneSMARCA4chr19:3982805chr19:11151983ENST000004440612835766_9311357.01614.0DomainHelicase ATP-binding
TgeneSMARCA4chr19:3982805chr19:11151983ENST0000059057427341084_12461357.01615.0DomainHelicase C-terminal
TgeneSMARCA4chr19:3982805chr19:11151983ENST000005905742734171_2061357.01615.0DomainQLQ
TgeneSMARCA4chr19:3982805chr19:11151983ENST000005905742734460_5321357.01615.0DomainHSA
TgeneSMARCA4chr19:3982805chr19:11151983ENST000005905742734766_9311357.01615.0DomainHelicase ATP-binding
TgeneSMARCA4chr19:3982805chr19:11151983ENST000003446262835881_8841390.01648.0MotifNote=DEGH box
TgeneSMARCA4chr19:3982805chr19:11151983ENST000004294162936881_8841390.01648.0MotifNote=DEGH box
TgeneSMARCA4chr19:3982805chr19:11151983ENST000004440612835881_8841357.01614.0MotifNote=DEGH box
TgeneSMARCA4chr19:3982805chr19:11151983ENST000005905742734881_8841357.01615.0MotifNote=DEGH box
TgeneSMARCA4chr19:3982805chr19:11151983ENST000003446262835779_7861390.01648.0Nucleotide bindingATP
TgeneSMARCA4chr19:3982805chr19:11151983ENST000004294162936779_7861390.01648.0Nucleotide bindingATP
TgeneSMARCA4chr19:3982805chr19:11151983ENST000004440612835779_7861357.01614.0Nucleotide bindingATP
TgeneSMARCA4chr19:3982805chr19:11151983ENST000005905742734779_7861357.01615.0Nucleotide bindingATP
TgeneSMARCA4chr19:3982805chr19:11151983ENST000003446262835462_7281390.01648.0RegionRNA-binding region which is sufficient for binding to lncRNA Evf2
TgeneSMARCA4chr19:3982805chr19:11151983ENST000004294162936462_7281390.01648.0RegionRNA-binding region which is sufficient for binding to lncRNA Evf2
TgeneSMARCA4chr19:3982805chr19:11151983ENST000004440612835462_7281357.01614.0RegionRNA-binding region which is sufficient for binding to lncRNA Evf2
TgeneSMARCA4chr19:3982805chr19:11151983ENST000005905742734462_7281357.01615.0RegionRNA-binding region which is sufficient for binding to lncRNA Evf2


Top

Fusion Gene Sequence for EEF2-SMARCA4


check button For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones.
>In-frame_ENST00000309311_ENST00000358026_TCGA-K1-A3PO-11A_EEF2_chr19_3982805_-_SMARCA4_chr19_11151983_length(transcript)=1941nt_BP=701nt
AGCGTTCTCTTCCGCCGTCGTCGCCGCCATCCTCGGCGCGACTCGCTTCTTTCGGTTCTACCTGGGAGAATCCACCGCCATCCGCCACCA
TGGTGAACTTCACGGTAGACCAGATCCGCGCCATCATGGACAAGAAGGCCAACATCCGCAACATGTCTGTCATCGCCCACGTGGACCATG
GCAAGTCCACGCTGACAGACTCCCTGGTGTGCAAGGCGGGCATCATCGCCTCGGCCCGGGCCGGGGAGACACGCTTCACTGATACCCGGA
AGGACGAGCAGGAGCGTTGCATCACCATCAAGTCAACTGCCATCTCCCTCTTCTACGAGCTCTCGGAGAATGACTTGAACTTCATCAAGC
AGAGCAAGGACGGTGCCGGCTTCCTCATCAACCTCATTGACTCCCCCGGGCATGTCGACTTCTCCTCGGAGGTGACTGCTGCCCTCCGAG
TCACCGATGGCGCATTGGTGGTGGTGGACTGCGTGTCAGGCGTGTGCGTGCAGACGGAGACAGTGCTGCGGCAGGCCATTGCCGAGCGCA
TCAAGCCTGTGCTGATGATGAACAAGATGGACCGCGCCCTGCTGGAGCTGCAGCTGGAGCCCGAGGAGCTCTACCAGACTTTCCAGCGCA
TCGTGGAGAACGTGAACGTCATCATCTCCACCTACGGCGAGGGCGAGAGCGGCCCCATGGGCAACATCATGGCCATCGAGGAGGGCACGC
TGGAGGAGATCGAAGAGGAGGTCCGGCAGAAGAAATCATCACGGAAGCGCAAGCGAGACAGCGACGCCGGCTCCTCCACCCCGACCACCA
GCACCCGCAGCCGCGACAAGGACGACGAGAGCAAGAAGCAGAAGAAGCGCGGGCGGCCGCCTGCCGAGAAACTCTCCCCTAACCCACCCA
ACCTCACCAAGAAGATGAAGAAGATTGTGGATGCCGTGATCAAGTACAAGGACAGCAGCAGTGGACGTCAGCTCAGCGAGGTCTTCATCC
AGCTGCCCTCGCGAAAGGAGCTGCCCGAGTACTACGAGCTCATCCGCAAGCCCGTGGACTTCAAGAAGATAAAGGAGCGCATTCGCAACC
ACAAGTACCGCAGCCTCAACGACCTAGAGAAGGACGTCATGCTCCTGTGCCAGAACGCACAGACCTTCAACCTGGAGGGCTCCCTGATCT
ATGAAGACTCCATCGTCTTGCAGTCGGTCTTCACCAGCGTGCGGCAGAAAATCGAGAAGGAGGATGACAGTGAAGGCGAGGAGAGTGAGG
AGGAGGAAGAGGGCGAGGAGGAAGGCTCCGAATCCGAATCTCGGTCCGTCAAAGTGAAGATCAAGCTTGGCCGGAAGGAGAAGGCACAGG
ACCGGCTGAAGGGCGGCCGGCGGCGGCCGAGCCGAGGGTCCCGAGCCAAGCCGGTCGTGAGTGACGATGACAGTGAGGAGGAACAAGAGG
AGGACCGCTCAGGAAGTGGCAGCGAAGAAGACTGAGCCCCGACATTCCAGTCTCGACCCCGAGCCCCTCGTTCCAGAGCTGAGATGGCAT
AGGCCTTAGCAGTAACGGGTAGCAGCAGATGTAGTTTCAGACTTGGAGTAAAACTGTATAAACAAAAGAATCTTCCATATTTATACAGCA
GAGAAGCTGTAGGACTGTTTGTGACTGGCCCTGTCCTGGCATCAGTAGCATCTGTAACAGCATTAACTGTCTTAAAGAGAGAGAGAGAGA
ATTCCGAATTGGGGAACACACGATACCTGTTTTTCTTTTCCGTTGCTGGCAGTACTGTTGCGCCGCAGTTTGGAGTCACTGTAGTTAAGT
GTGGATGCATGTGCGTCACCGTCCACTCCTCCTACTGTATTTTATTGGACAGGTCAGACTCGCCGGGGGCCCGGCGAGGGTATGTCAGTG

>In-frame_ENST00000309311_ENST00000358026_TCGA-K1-A3PO-11A_EEF2_chr19_3982805_-_SMARCA4_chr19_11151983_length(amino acids)=461AA_start in transcript=89_stop in transcript=1474
MVNFTVDQIRAIMDKKANIRNMSVIAHVDHGKSTLTDSLVCKAGIIASARAGETRFTDTRKDEQERCITIKSTAISLFYELSENDLNFIK
QSKDGAGFLINLIDSPGHVDFSSEVTAALRVTDGALVVVDCVSGVCVQTETVLRQAIAERIKPVLMMNKMDRALLELQLEPEELYQTFQR
IVENVNVIISTYGEGESGPMGNIMAIEEGTLEEIEEEVRQKKSSRKRKRDSDAGSSTPTTSTRSRDKDDESKKQKKRGRPPAEKLSPNPP
NLTKKMKKIVDAVIKYKDSSSGRQLSEVFIQLPSRKELPEYYELIRKPVDFKKIKERIRNHKYRSLNDLEKDVMLLCQNAQTFNLEGSLI
YEDSIVLQSVFTSVRQKIEKEDDSEGEESEEEEEGEEEGSESESRSVKVKIKLGRKEKAQDRLKGGRRRPSRGSRAKPVVSDDDSEEEQE

--------------------------------------------------------------
>In-frame_ENST00000309311_ENST00000344626_TCGA-K1-A3PO-11A_EEF2_chr19_3982805_-_SMARCA4_chr19_11151983_length(transcript)=1718nt_BP=701nt
AGCGTTCTCTTCCGCCGTCGTCGCCGCCATCCTCGGCGCGACTCGCTTCTTTCGGTTCTACCTGGGAGAATCCACCGCCATCCGCCACCA
TGGTGAACTTCACGGTAGACCAGATCCGCGCCATCATGGACAAGAAGGCCAACATCCGCAACATGTCTGTCATCGCCCACGTGGACCATG
GCAAGTCCACGCTGACAGACTCCCTGGTGTGCAAGGCGGGCATCATCGCCTCGGCCCGGGCCGGGGAGACACGCTTCACTGATACCCGGA
AGGACGAGCAGGAGCGTTGCATCACCATCAAGTCAACTGCCATCTCCCTCTTCTACGAGCTCTCGGAGAATGACTTGAACTTCATCAAGC
AGAGCAAGGACGGTGCCGGCTTCCTCATCAACCTCATTGACTCCCCCGGGCATGTCGACTTCTCCTCGGAGGTGACTGCTGCCCTCCGAG
TCACCGATGGCGCATTGGTGGTGGTGGACTGCGTGTCAGGCGTGTGCGTGCAGACGGAGACAGTGCTGCGGCAGGCCATTGCCGAGCGCA
TCAAGCCTGTGCTGATGATGAACAAGATGGACCGCGCCCTGCTGGAGCTGCAGCTGGAGCCCGAGGAGCTCTACCAGACTTTCCAGCGCA
TCGTGGAGAACGTGAACGTCATCATCTCCACCTACGGCGAGGGCGAGAGCGGCCCCATGGGCAACATCATGGCCATCGAGGAGGGCACGC
TGGAGGAGATCGAAGAGGAGGTCCGGCAGAAGAAATCATCACGGAAGCGCAAGCGAGACAGCGACGCCGGCTCCTCCACCCCGACCACCA
GCACCCGCAGCCGCGACAAGGACGACGAGAGCAAGAAGCAGAAGAAGCGCGGGCGGCCGCCTGCCGAGAAACTCTCCCCTAACCCACCCA
ACCTCACCAAGAAGATGAAGAAGATTGTGGATGCCGTGATCAAGTACAAGGACAGCAGCAGTGGACGTCAGCTCAGCGAGGTCTTCATCC
AGCTGCCCTCGCGAAAGGAGCTGCCCGAGTACTACGAGCTCATCCGCAAGCCCGTGGACTTCAAGAAGATAAAGGAGCGCATTCGCAACC
ACAAGTACCGCAGCCTCAACGACCTAGAGAAGGACGTCATGCTCCTGTGCCAGAACGCACAGACCTTCAACCTGGAGGGCTCCCTGATCT
ATGAAGACTCCATCGTCTTGCAGTCGGTCTTCACCAGCGTGCGGCAGAAAATCGAGAAGGAGGATGACAGTGAAGGCGAGGAGAGTGAGG
AGGAGGAAGAGGGCGAGGAGGAAGGCTCCGAATCCGAATCTCGGTCCGTCAAAGTGAAGATCAAGCTTGGCCGGAAGGAGAAGGCACAGG
ACCGGCTGAAGGGCGGCCGGCGGCGGCCGAGCCGAGGGTCCCGAGCCAAGCCGGTCGTGAGTGACGATGACAGTGAGGAGGAACAAGAGG
AGGACCGCTCAGGAAGTGGCAGCGAAGAAGACTGAGCCCCGACATTCCAGTCTCGACCCCGAGCCCCTCGTTCCAGAGCTGAGATGGCAT
AGGCCTTAGCAGTAACGGGTAGCAGCAGATGTAGTTTCAGACTTGGAGTAAAACTGTATAAACAAAAGAATCTTCCATATTTATACAGCA
GAGAAGCTGTAGGACTGTTTGTGACTGGCCCTGTCCTGGCATCAGTAGCATCTGTAACAGCATTAACTGTCTTAAAGAGAGAGAGAGAGA

>In-frame_ENST00000309311_ENST00000344626_TCGA-K1-A3PO-11A_EEF2_chr19_3982805_-_SMARCA4_chr19_11151983_length(amino acids)=461AA_start in transcript=89_stop in transcript=1474
MVNFTVDQIRAIMDKKANIRNMSVIAHVDHGKSTLTDSLVCKAGIIASARAGETRFTDTRKDEQERCITIKSTAISLFYELSENDLNFIK
QSKDGAGFLINLIDSPGHVDFSSEVTAALRVTDGALVVVDCVSGVCVQTETVLRQAIAERIKPVLMMNKMDRALLELQLEPEELYQTFQR
IVENVNVIISTYGEGESGPMGNIMAIEEGTLEEIEEEVRQKKSSRKRKRDSDAGSSTPTTSTRSRDKDDESKKQKKRGRPPAEKLSPNPP
NLTKKMKKIVDAVIKYKDSSSGRQLSEVFIQLPSRKELPEYYELIRKPVDFKKIKERIRNHKYRSLNDLEKDVMLLCQNAQTFNLEGSLI
YEDSIVLQSVFTSVRQKIEKEDDSEGEESEEEEEGEEEGSESESRSVKVKIKLGRKEKAQDRLKGGRRRPSRGSRAKPVVSDDDSEEEQE

--------------------------------------------------------------
>In-frame_ENST00000309311_ENST00000429416_TCGA-K1-A3PO-11A_EEF2_chr19_3982805_-_SMARCA4_chr19_11151983_length(transcript)=1941nt_BP=701nt
AGCGTTCTCTTCCGCCGTCGTCGCCGCCATCCTCGGCGCGACTCGCTTCTTTCGGTTCTACCTGGGAGAATCCACCGCCATCCGCCACCA
TGGTGAACTTCACGGTAGACCAGATCCGCGCCATCATGGACAAGAAGGCCAACATCCGCAACATGTCTGTCATCGCCCACGTGGACCATG
GCAAGTCCACGCTGACAGACTCCCTGGTGTGCAAGGCGGGCATCATCGCCTCGGCCCGGGCCGGGGAGACACGCTTCACTGATACCCGGA
AGGACGAGCAGGAGCGTTGCATCACCATCAAGTCAACTGCCATCTCCCTCTTCTACGAGCTCTCGGAGAATGACTTGAACTTCATCAAGC
AGAGCAAGGACGGTGCCGGCTTCCTCATCAACCTCATTGACTCCCCCGGGCATGTCGACTTCTCCTCGGAGGTGACTGCTGCCCTCCGAG
TCACCGATGGCGCATTGGTGGTGGTGGACTGCGTGTCAGGCGTGTGCGTGCAGACGGAGACAGTGCTGCGGCAGGCCATTGCCGAGCGCA
TCAAGCCTGTGCTGATGATGAACAAGATGGACCGCGCCCTGCTGGAGCTGCAGCTGGAGCCCGAGGAGCTCTACCAGACTTTCCAGCGCA
TCGTGGAGAACGTGAACGTCATCATCTCCACCTACGGCGAGGGCGAGAGCGGCCCCATGGGCAACATCATGGCCATCGAGGAGGGCACGC
TGGAGGAGATCGAAGAGGAGGTCCGGCAGAAGAAATCATCACGGAAGCGCAAGCGAGACAGCGACGCCGGCTCCTCCACCCCGACCACCA
GCACCCGCAGCCGCGACAAGGACGACGAGAGCAAGAAGCAGAAGAAGCGCGGGCGGCCGCCTGCCGAGAAACTCTCCCCTAACCCACCCA
ACCTCACCAAGAAGATGAAGAAGATTGTGGATGCCGTGATCAAGTACAAGGACAGCAGCAGTGGACGTCAGCTCAGCGAGGTCTTCATCC
AGCTGCCCTCGCGAAAGGAGCTGCCCGAGTACTACGAGCTCATCCGCAAGCCCGTGGACTTCAAGAAGATAAAGGAGCGCATTCGCAACC
ACAAGTACCGCAGCCTCAACGACCTAGAGAAGGACGTCATGCTCCTGTGCCAGAACGCACAGACCTTCAACCTGGAGGGCTCCCTGATCT
ATGAAGACTCCATCGTCTTGCAGTCGGTCTTCACCAGCGTGCGGCAGAAAATCGAGAAGGAGGATGACAGTGAAGGCGAGGAGAGTGAGG
AGGAGGAAGAGGGCGAGGAGGAAGGCTCCGAATCCGAATCTCGGTCCGTCAAAGTGAAGATCAAGCTTGGCCGGAAGGAGAAGGCACAGG
ACCGGCTGAAGGGCGGCCGGCGGCGGCCGAGCCGAGGGTCCCGAGCCAAGCCGGTCGTGAGTGACGATGACAGTGAGGAGGAACAAGAGG
AGGACCGCTCAGGAAGTGGCAGCGAAGAAGACTGAGCCCCGACATTCCAGTCTCGACCCCGAGCCCCTCGTTCCAGAGCTGAGATGGCAT
AGGCCTTAGCAGTAACGGGTAGCAGCAGATGTAGTTTCAGACTTGGAGTAAAACTGTATAAACAAAAGAATCTTCCATATTTATACAGCA
GAGAAGCTGTAGGACTGTTTGTGACTGGCCCTGTCCTGGCATCAGTAGCATCTGTAACAGCATTAACTGTCTTAAAGAGAGAGAGAGAGA
ATTCCGAATTGGGGAACACACGATACCTGTTTTTCTTTTCCGTTGCTGGCAGTACTGTTGCGCCGCAGTTTGGAGTCACTGTAGTTAAGT
GTGGATGCATGTGCGTCACCGTCCACTCCTCCTACTGTATTTTATTGGACAGGTCAGACTCGCCGGGGGCCCGGCGAGGGTATGTCAGTG

>In-frame_ENST00000309311_ENST00000429416_TCGA-K1-A3PO-11A_EEF2_chr19_3982805_-_SMARCA4_chr19_11151983_length(amino acids)=461AA_start in transcript=89_stop in transcript=1474
MVNFTVDQIRAIMDKKANIRNMSVIAHVDHGKSTLTDSLVCKAGIIASARAGETRFTDTRKDEQERCITIKSTAISLFYELSENDLNFIK
QSKDGAGFLINLIDSPGHVDFSSEVTAALRVTDGALVVVDCVSGVCVQTETVLRQAIAERIKPVLMMNKMDRALLELQLEPEELYQTFQR
IVENVNVIISTYGEGESGPMGNIMAIEEGTLEEIEEEVRQKKSSRKRKRDSDAGSSTPTTSTRSRDKDDESKKQKKRGRPPAEKLSPNPP
NLTKKMKKIVDAVIKYKDSSSGRQLSEVFIQLPSRKELPEYYELIRKPVDFKKIKERIRNHKYRSLNDLEKDVMLLCQNAQTFNLEGSLI
YEDSIVLQSVFTSVRQKIEKEDDSEGEESEEEEEGEEEGSESESRSVKVKIKLGRKEKAQDRLKGGRRRPSRGSRAKPVVSDDDSEEEQE

--------------------------------------------------------------
>In-frame_ENST00000309311_ENST00000541122_TCGA-K1-A3PO-11A_EEF2_chr19_3982805_-_SMARCA4_chr19_11151983_length(transcript)=1474nt_BP=701nt
AGCGTTCTCTTCCGCCGTCGTCGCCGCCATCCTCGGCGCGACTCGCTTCTTTCGGTTCTACCTGGGAGAATCCACCGCCATCCGCCACCA
TGGTGAACTTCACGGTAGACCAGATCCGCGCCATCATGGACAAGAAGGCCAACATCCGCAACATGTCTGTCATCGCCCACGTGGACCATG
GCAAGTCCACGCTGACAGACTCCCTGGTGTGCAAGGCGGGCATCATCGCCTCGGCCCGGGCCGGGGAGACACGCTTCACTGATACCCGGA
AGGACGAGCAGGAGCGTTGCATCACCATCAAGTCAACTGCCATCTCCCTCTTCTACGAGCTCTCGGAGAATGACTTGAACTTCATCAAGC
AGAGCAAGGACGGTGCCGGCTTCCTCATCAACCTCATTGACTCCCCCGGGCATGTCGACTTCTCCTCGGAGGTGACTGCTGCCCTCCGAG
TCACCGATGGCGCATTGGTGGTGGTGGACTGCGTGTCAGGCGTGTGCGTGCAGACGGAGACAGTGCTGCGGCAGGCCATTGCCGAGCGCA
TCAAGCCTGTGCTGATGATGAACAAGATGGACCGCGCCCTGCTGGAGCTGCAGCTGGAGCCCGAGGAGCTCTACCAGACTTTCCAGCGCA
TCGTGGAGAACGTGAACGTCATCATCTCCACCTACGGCGAGGGCGAGAGCGGCCCCATGGGCAACATCATGCCATCGAGGAGGGCACGCT
GGAGGAGATCGAAGAGGAGGTCCGGCAGAAGAAATCATCACGGAAGCGCAAGCGAGACAGCGACGCCGGCTCCTCCACCCCGACCACCAG
CACCCGCAGCCGCGACAAGGACGACGAGAGCAAGAAGCAGAAGAAGCGCGGGCGGCCGCCTGCCGAGAAACTCTCCCCTAACCCACCCAA
CCTCACCAAGAAGATGAAGAAGATTGTGGATGCCGTGATCAAGTACAAGGACAGCAGCAGTGGACGTCAGCTCAGCGAGGTCTTCATCCA
GCTGCCCTCGCGAAAGGAGCTGCCCGAGTACTACGAGCTCATCCGCAAGCCCGTGGACTTCAAGAAGATAAAGGAGCGCATTCGCAACCA
CAAGTACCGCAGCCTCAACGACCTAGAGAAGGACGTCATGCTCCTGTGCCAGAACGCACAGACCTTCAACCTGGAGGGCTCCCTGATCTA
TGAAGACTCCATCGTCTTGCAGTCGGTCTTCACCAGCGTGCGGCAGAAAATCGAGAAGGAGGATGACAGTGAAGGCGAGGAGAGTGAGGA
GGAGGAAGAGGGCGAGGAGGAAGGCTCCGAATCCGAATCTCGGTCCGTCAAAGTGAAGATCAAGCTTGGCCGGAAGGAGAAGGCACAGGA
CCGGCTGAAGGGCGGCCGGCGGCGGCCGAGCCGAGGGTCCCGAGCCAAGCCGGTCGTGAGTGACGATGACAGTGAGGAGGAACAAGAGGA

>In-frame_ENST00000309311_ENST00000541122_TCGA-K1-A3PO-11A_EEF2_chr19_3982805_-_SMARCA4_chr19_11151983_length(amino acids)=332AA_start in transcript=478_stop in transcript=1473
MRVRRVRADGDSAAAGHCRAHQACADDEQDGPRPAGAAAGARGALPDFPAHRGERERHHLHLRRGRERPHGQHHAIEEGTLEEIEEEVRQ
KKSSRKRKRDSDAGSSTPTTSTRSRDKDDESKKQKKRGRPPAEKLSPNPPNLTKKMKKIVDAVIKYKDSSSGRQLSEVFIQLPSRKELPE
YYELIRKPVDFKKIKERIRNHKYRSLNDLEKDVMLLCQNAQTFNLEGSLIYEDSIVLQSVFTSVRQKIEKEDDSEGEESEEEEEGEEEGS

--------------------------------------------------------------
>In-frame_ENST00000309311_ENST00000589677_TCGA-K1-A3PO-11A_EEF2_chr19_3982805_-_SMARCA4_chr19_11151983_length(transcript)=1471nt_BP=701nt
AGCGTTCTCTTCCGCCGTCGTCGCCGCCATCCTCGGCGCGACTCGCTTCTTTCGGTTCTACCTGGGAGAATCCACCGCCATCCGCCACCA
TGGTGAACTTCACGGTAGACCAGATCCGCGCCATCATGGACAAGAAGGCCAACATCCGCAACATGTCTGTCATCGCCCACGTGGACCATG
GCAAGTCCACGCTGACAGACTCCCTGGTGTGCAAGGCGGGCATCATCGCCTCGGCCCGGGCCGGGGAGACACGCTTCACTGATACCCGGA
AGGACGAGCAGGAGCGTTGCATCACCATCAAGTCAACTGCCATCTCCCTCTTCTACGAGCTCTCGGAGAATGACTTGAACTTCATCAAGC
AGAGCAAGGACGGTGCCGGCTTCCTCATCAACCTCATTGACTCCCCCGGGCATGTCGACTTCTCCTCGGAGGTGACTGCTGCCCTCCGAG
TCACCGATGGCGCATTGGTGGTGGTGGACTGCGTGTCAGGCGTGTGCGTGCAGACGGAGACAGTGCTGCGGCAGGCCATTGCCGAGCGCA
TCAAGCCTGTGCTGATGATGAACAAGATGGACCGCGCCCTGCTGGAGCTGCAGCTGGAGCCCGAGGAGCTCTACCAGACTTTCCAGCGCA
TCGTGGAGAACGTGAACGTCATCATCTCCACCTACGGCGAGGGCGAGAGCGGCCCCATGGGCAACATCATGCCATCGAGGAGGGCACGCT
GGAGGAGATCGAAGAGGAGGTCCGGCAGAAGAAATCATCACGGAAGCGCAAGCGAGACAGCGACGCCGGCTCCTCCACCCCGACCACCAG
CACCCGCAGCCGCGACAAGGACGACGAGAGCAAGAAGCAGAAGAAGCGCGGGCGGCCGCCTGCCGAGAAACTCTCCCCTAACCCACCCAA
CCTCACCAAGAAGATGAAGAAGATTGTGGATGCCGTGATCAAGTACAAGGACAGCAGTGGACGTCAGCTCAGCGAGGTCTTCATCCAGCT
GCCCTCGCGAAAGGAGCTGCCCGAGTACTACGAGCTCATCCGCAAGCCCGTGGACTTCAAGAAGATAAAGGAGCGCATTCGCAACCACAA
GTACCGCAGCCTCAACGACCTAGAGAAGGACGTCATGCTCCTGTGCCAGAACGCACAGACCTTCAACCTGGAGGGCTCCCTGATCTATGA
AGACTCCATCGTCTTGCAGTCGGTCTTCACCAGCGTGCGGCAGAAAATCGAGAAGGAGGATGACAGTGAAGGCGAGGAGAGTGAGGAGGA
GGAAGAGGGCGAGGAGGAAGGCTCCGAATCCGAATCTCGGTCCGTCAAAGTGAAGATCAAGCTTGGCCGGAAGGAGAAGGCACAGGACCG
GCTGAAGGGCGGCCGGCGGCGGCCGAGCCGAGGGTCCCGAGCCAAGCCGGTCGTGAGTGACGATGACAGTGAGGAGGAACAAGAGGAGGA

>In-frame_ENST00000309311_ENST00000589677_TCGA-K1-A3PO-11A_EEF2_chr19_3982805_-_SMARCA4_chr19_11151983_length(amino acids)=331AA_start in transcript=478_stop in transcript=1470
MRVRRVRADGDSAAAGHCRAHQACADDEQDGPRPAGAAAGARGALPDFPAHRGERERHHLHLRRGRERPHGQHHAIEEGTLEEIEEEVRQ
KKSSRKRKRDSDAGSSTPTTSTRSRDKDDESKKQKKRGRPPAEKLSPNPPNLTKKMKKIVDAVIKYKDSSGRQLSEVFIQLPSRKELPEY
YELIRKPVDFKKIKERIRNHKYRSLNDLEKDVMLLCQNAQTFNLEGSLIYEDSIVLQSVFTSVRQKIEKEDDSEGEESEEEEEGEEEGSE

--------------------------------------------------------------
>In-frame_ENST00000309311_ENST00000444061_TCGA-K1-A3PO-11A_EEF2_chr19_3982805_-_SMARCA4_chr19_11151983_length(transcript)=1472nt_BP=701nt
AGCGTTCTCTTCCGCCGTCGTCGCCGCCATCCTCGGCGCGACTCGCTTCTTTCGGTTCTACCTGGGAGAATCCACCGCCATCCGCCACCA
TGGTGAACTTCACGGTAGACCAGATCCGCGCCATCATGGACAAGAAGGCCAACATCCGCAACATGTCTGTCATCGCCCACGTGGACCATG
GCAAGTCCACGCTGACAGACTCCCTGGTGTGCAAGGCGGGCATCATCGCCTCGGCCCGGGCCGGGGAGACACGCTTCACTGATACCCGGA
AGGACGAGCAGGAGCGTTGCATCACCATCAAGTCAACTGCCATCTCCCTCTTCTACGAGCTCTCGGAGAATGACTTGAACTTCATCAAGC
AGAGCAAGGACGGTGCCGGCTTCCTCATCAACCTCATTGACTCCCCCGGGCATGTCGACTTCTCCTCGGAGGTGACTGCTGCCCTCCGAG
TCACCGATGGCGCATTGGTGGTGGTGGACTGCGTGTCAGGCGTGTGCGTGCAGACGGAGACAGTGCTGCGGCAGGCCATTGCCGAGCGCA
TCAAGCCTGTGCTGATGATGAACAAGATGGACCGCGCCCTGCTGGAGCTGCAGCTGGAGCCCGAGGAGCTCTACCAGACTTTCCAGCGCA
TCGTGGAGAACGTGAACGTCATCATCTCCACCTACGGCGAGGGCGAGAGCGGCCCCATGGGCAACATCATGGCCATCGAGGAGGGCACGC
TGGAGGAGATCGAAGAGGAGGTCCGGCAGAAGAAATCATCACGGAAGCGCAAGCGAGACAGCGACGCCGGCTCCTCCACCCCGACCACCA
GCACCCGCAGCCGCGACAAGGACGACGAGAGCAAGAAGCAGAAGAAGCGCGGGCGGCCGCCTGCCGAGAAACTCTCCCCTAACCCACCCA
ACCTCACCAAGAAGATGAAGAAGATTGTGGATGCCGTGATCAAGTACAAGGACAGCAGTGGACGTCAGCTCAGCGAGGTCTTCATCCAGC
TGCCCTCGCGAAAGGAGCTGCCCGAGTACTACGAGCTCATCCGCAAGCCCGTGGACTTCAAGAAGATAAAGGAGCGCATTCGCAACCACA
AGTACCGCAGCCTCAACGACCTAGAGAAGGACGTCATGCTCCTGTGCCAGAACGCACAGACCTTCAACCTGGAGGGCTCCCTGATCTATG
AAGACTCCATCGTCTTGCAGTCGGTCTTCACCAGCGTGCGGCAGAAAATCGAGAAGGAGGATGACAGTGAAGGCGAGGAGAGTGAGGAGG
AGGAAGAGGGCGAGGAGGAAGGCTCCGAATCCGAATCTCGGTCCGTCAAAGTGAAGATCAAGCTTGGCCGGAAGGAGAAGGCACAGGACC
GGCTGAAGGGCGGCCGGCGGCGGCCGAGCCGAGGGTCCCGAGCCAAGCCGGTCGTGAGTGACGATGACAGTGAGGAGGAACAAGAGGAGG

>In-frame_ENST00000309311_ENST00000444061_TCGA-K1-A3PO-11A_EEF2_chr19_3982805_-_SMARCA4_chr19_11151983_length(amino acids)=461AA_start in transcript=89_stop in transcript=1471
MVNFTVDQIRAIMDKKANIRNMSVIAHVDHGKSTLTDSLVCKAGIIASARAGETRFTDTRKDEQERCITIKSTAISLFYELSENDLNFIK
QSKDGAGFLINLIDSPGHVDFSSEVTAALRVTDGALVVVDCVSGVCVQTETVLRQAIAERIKPVLMMNKMDRALLELQLEPEELYQTFQR
IVENVNVIISTYGEGESGPMGNIMAIEEGTLEEIEEEVRQKKSSRKRKRDSDAGSSTPTTSTRSRDKDDESKKQKKRGRPPAEKLSPNPP
NLTKKMKKIVDAVIKYKDSSGRQLSEVFIQLPSRKELPEYYELIRKPVDFKKIKERIRNHKYRSLNDLEKDVMLLCQNAQTFNLEGSLIY
EDSIVLQSVFTSVRQKIEKEDDSEGEESEEEEEGEEEGSESESRSVKVKIKLGRKEKAQDRLKGGRRRPSRGSRAKPVVSDDDSEEEQEE

--------------------------------------------------------------
>In-frame_ENST00000309311_ENST00000590574_TCGA-K1-A3PO-11A_EEF2_chr19_3982805_-_SMARCA4_chr19_11151983_length(transcript)=1475nt_BP=701nt
AGCGTTCTCTTCCGCCGTCGTCGCCGCCATCCTCGGCGCGACTCGCTTCTTTCGGTTCTACCTGGGAGAATCCACCGCCATCCGCCACCA
TGGTGAACTTCACGGTAGACCAGATCCGCGCCATCATGGACAAGAAGGCCAACATCCGCAACATGTCTGTCATCGCCCACGTGGACCATG
GCAAGTCCACGCTGACAGACTCCCTGGTGTGCAAGGCGGGCATCATCGCCTCGGCCCGGGCCGGGGAGACACGCTTCACTGATACCCGGA
AGGACGAGCAGGAGCGTTGCATCACCATCAAGTCAACTGCCATCTCCCTCTTCTACGAGCTCTCGGAGAATGACTTGAACTTCATCAAGC
AGAGCAAGGACGGTGCCGGCTTCCTCATCAACCTCATTGACTCCCCCGGGCATGTCGACTTCTCCTCGGAGGTGACTGCTGCCCTCCGAG
TCACCGATGGCGCATTGGTGGTGGTGGACTGCGTGTCAGGCGTGTGCGTGCAGACGGAGACAGTGCTGCGGCAGGCCATTGCCGAGCGCA
TCAAGCCTGTGCTGATGATGAACAAGATGGACCGCGCCCTGCTGGAGCTGCAGCTGGAGCCCGAGGAGCTCTACCAGACTTTCCAGCGCA
TCGTGGAGAACGTGAACGTCATCATCTCCACCTACGGCGAGGGCGAGAGCGGCCCCATGGGCAACATCATGGCCATCGAGGAGGGCACGC
TGGAGGAGATCGAAGAGGAGGTCCGGCAGAAGAAATCATCACGGAAGCGCAAGCGAGACAGCGACGCCGGCTCCTCCACCCCGACCACCA
GCACCCGCAGCCGCGACAAGGACGACGAGAGCAAGAAGCAGAAGAAGCGCGGGCGGCCGCCTGCCGAGAAACTCTCCCCTAACCCACCCA
ACCTCACCAAGAAGATGAAGAAGATTGTGGATGCCGTGATCAAGTACAAGGACAGCAGCAGTGGACGTCAGCTCAGCGAGGTCTTCATCC
AGCTGCCCTCGCGAAAGGAGCTGCCCGAGTACTACGAGCTCATCCGCAAGCCCGTGGACTTCAAGAAGATAAAGGAGCGCATTCGCAACC
ACAAGTACCGCAGCCTCAACGACCTAGAGAAGGACGTCATGCTCCTGTGCCAGAACGCACAGACCTTCAACCTGGAGGGCTCCCTGATCT
ATGAAGACTCCATCGTCTTGCAGTCGGTCTTCACCAGCGTGCGGCAGAAAATCGAGAAGGAGGATGACAGTGAAGGCGAGGAGAGTGAGG
AGGAGGAAGAGGGCGAGGAGGAAGGCTCCGAATCCGAATCTCGGTCCGTCAAAGTGAAGATCAAGCTTGGCCGGAAGGAGAAGGCACAGG
ACCGGCTGAAGGGCGGCCGGCGGCGGCCGAGCCGAGGGTCCCGAGCCAAGCCGGTCGTGAGTGACGATGACAGTGAGGAGGAACAAGAGG

>In-frame_ENST00000309311_ENST00000590574_TCGA-K1-A3PO-11A_EEF2_chr19_3982805_-_SMARCA4_chr19_11151983_length(amino acids)=462AA_start in transcript=89_stop in transcript=1474
MVNFTVDQIRAIMDKKANIRNMSVIAHVDHGKSTLTDSLVCKAGIIASARAGETRFTDTRKDEQERCITIKSTAISLFYELSENDLNFIK
QSKDGAGFLINLIDSPGHVDFSSEVTAALRVTDGALVVVDCVSGVCVQTETVLRQAIAERIKPVLMMNKMDRALLELQLEPEELYQTFQR
IVENVNVIISTYGEGESGPMGNIMAIEEGTLEEIEEEVRQKKSSRKRKRDSDAGSSTPTTSTRSRDKDDESKKQKKRGRPPAEKLSPNPP
NLTKKMKKIVDAVIKYKDSSSGRQLSEVFIQLPSRKELPEYYELIRKPVDFKKIKERIRNHKYRSLNDLEKDVMLLCQNAQTFNLEGSLI
YEDSIVLQSVFTSVRQKIEKEDDSEGEESEEEEEGEEEGSESESRSVKVKIKLGRKEKAQDRLKGGRRRPSRGSRAKPVVSDDDSEEEQE

--------------------------------------------------------------
>In-frame_ENST00000309311_ENST00000413806_TCGA-K1-A3PO-11A_EEF2_chr19_3982805_-_SMARCA4_chr19_11151983_length(transcript)=1940nt_BP=701nt
AGCGTTCTCTTCCGCCGTCGTCGCCGCCATCCTCGGCGCGACTCGCTTCTTTCGGTTCTACCTGGGAGAATCCACCGCCATCCGCCACCA
TGGTGAACTTCACGGTAGACCAGATCCGCGCCATCATGGACAAGAAGGCCAACATCCGCAACATGTCTGTCATCGCCCACGTGGACCATG
GCAAGTCCACGCTGACAGACTCCCTGGTGTGCAAGGCGGGCATCATCGCCTCGGCCCGGGCCGGGGAGACACGCTTCACTGATACCCGGA
AGGACGAGCAGGAGCGTTGCATCACCATCAAGTCAACTGCCATCTCCCTCTTCTACGAGCTCTCGGAGAATGACTTGAACTTCATCAAGC
AGAGCAAGGACGGTGCCGGCTTCCTCATCAACCTCATTGACTCCCCCGGGCATGTCGACTTCTCCTCGGAGGTGACTGCTGCCCTCCGAG
TCACCGATGGCGCATTGGTGGTGGTGGACTGCGTGTCAGGCGTGTGCGTGCAGACGGAGACAGTGCTGCGGCAGGCCATTGCCGAGCGCA
TCAAGCCTGTGCTGATGATGAACAAGATGGACCGCGCCCTGCTGGAGCTGCAGCTGGAGCCCGAGGAGCTCTACCAGACTTTCCAGCGCA
TCGTGGAGAACGTGAACGTCATCATCTCCACCTACGGCGAGGGCGAGAGCGGCCCCATGGGCAACATCATGCCATCGAGGAGGGCACGCT
GGAGGAGATCGAAGAGGAGGTCCGGCAGAAGAAATCATCACGGAAGCGCAAGCGAGACAGCGACGCCGGCTCCTCCACCCCGACCACCAG
CACCCGCAGCCGCGACAAGGACGACGAGAGCAAGAAGCAGAAGAAGCGCGGGCGGCCGCCTGCCGAGAAACTCTCCCCTAACCCACCCAA
CCTCACCAAGAAGATGAAGAAGATTGTGGATGCCGTGATCAAGTACAAGGACAGCAGCAGTGGACGTCAGCTCAGCGAGGTCTTCATCCA
GCTGCCCTCGCGAAAGGAGCTGCCCGAGTACTACGAGCTCATCCGCAAGCCCGTGGACTTCAAGAAGATAAAGGAGCGCATTCGCAACCA
CAAGTACCGCAGCCTCAACGACCTAGAGAAGGACGTCATGCTCCTGTGCCAGAACGCACAGACCTTCAACCTGGAGGGCTCCCTGATCTA
TGAAGACTCCATCGTCTTGCAGTCGGTCTTCACCAGCGTGCGGCAGAAAATCGAGAAGGAGGATGACAGTGAAGGCGAGGAGAGTGAGGA
GGAGGAAGAGGGCGAGGAGGAAGGCTCCGAATCCGAATCTCGGTCCGTCAAAGTGAAGATCAAGCTTGGCCGGAAGGAGAAGGCACAGGA
CCGGCTGAAGGGCGGCCGGCGGCGGCCGAGCCGAGGGTCCCGAGCCAAGCCGGTCGTGAGTGACGATGACAGTGAGGAGGAACAAGAGGA
GGACCGCTCAGGAAGTGGCAGCGAAGAAGACTGAGCCCCGACATTCCAGTCTCGACCCCGAGCCCCTCGTTCCAGAGCTGAGATGGCATA
GGCCTTAGCAGTAACGGGTAGCAGCAGATGTAGTTTCAGACTTGGAGTAAAACTGTATAAACAAAAGAATCTTCCATATTTATACAGCAG
AGAAGCTGTAGGACTGTTTGTGACTGGCCCTGTCCTGGCATCAGTAGCATCTGTAACAGCATTAACTGTCTTAAAGAGAGAGAGAGAGAA
TTCCGAATTGGGGAACACACGATACCTGTTTTTCTTTTCCGTTGCTGGCAGTACTGTTGCGCCGCAGTTTGGAGTCACTGTAGTTAAGTG
TGGATGCATGTGCGTCACCGTCCACTCCTCCTACTGTATTTTATTGGACAGGTCAGACTCGCCGGGGGCCCGGCGAGGGTATGTCAGTGT

>In-frame_ENST00000309311_ENST00000413806_TCGA-K1-A3PO-11A_EEF2_chr19_3982805_-_SMARCA4_chr19_11151983_length(amino acids)=331AA_start in transcript=478_stop in transcript=1473
MRVRRVRADGDSAAAGHCRAHQACADDEQDGPRPAGAAAGARGALPDFPAHRGERERHHLHLRRGRERPHGQHHAIEEGTLEEIEEEVRQ
KKSSRKRKRDSDAGSSTPTTSTRSRDKDDESKKQKKRGRPPAEKLSPNPPNLTKKMKKIVDAVIKYKDSSSGRQLSEVFIQLPSRKELPE
YYELIRKPVDFKKIKERIRNHKYRSLNDLEKDVMLLCQNAQTFNLEGSLIYEDSIVLQSVFTSVRQKIEKEDDSEGEESEEEEEGEEEGS

--------------------------------------------------------------
>In-frame_ENST00000309311_ENST00000450717_TCGA-K1-A3PO-11A_EEF2_chr19_3982805_-_SMARCA4_chr19_11151983_length(transcript)=1937nt_BP=701nt
AGCGTTCTCTTCCGCCGTCGTCGCCGCCATCCTCGGCGCGACTCGCTTCTTTCGGTTCTACCTGGGAGAATCCACCGCCATCCGCCACCA
TGGTGAACTTCACGGTAGACCAGATCCGCGCCATCATGGACAAGAAGGCCAACATCCGCAACATGTCTGTCATCGCCCACGTGGACCATG
GCAAGTCCACGCTGACAGACTCCCTGGTGTGCAAGGCGGGCATCATCGCCTCGGCCCGGGCCGGGGAGACACGCTTCACTGATACCCGGA
AGGACGAGCAGGAGCGTTGCATCACCATCAAGTCAACTGCCATCTCCCTCTTCTACGAGCTCTCGGAGAATGACTTGAACTTCATCAAGC
AGAGCAAGGACGGTGCCGGCTTCCTCATCAACCTCATTGACTCCCCCGGGCATGTCGACTTCTCCTCGGAGGTGACTGCTGCCCTCCGAG
TCACCGATGGCGCATTGGTGGTGGTGGACTGCGTGTCAGGCGTGTGCGTGCAGACGGAGACAGTGCTGCGGCAGGCCATTGCCGAGCGCA
TCAAGCCTGTGCTGATGATGAACAAGATGGACCGCGCCCTGCTGGAGCTGCAGCTGGAGCCCGAGGAGCTCTACCAGACTTTCCAGCGCA
TCGTGGAGAACGTGAACGTCATCATCTCCACCTACGGCGAGGGCGAGAGCGGCCCCATGGGCAACATCATGCCATCGAGGAGGGCACGCT
GGAGGAGATCGAAGAGGAGGTCCGGCAGAAGAAATCATCACGGAAGCGCAAGCGAGACAGCGACGCCGGCTCCTCCACCCCGACCACCAG
CACCCGCAGCCGCGACAAGGACGACGAGAGCAAGAAGCAGAAGAAGCGCGGGCGGCCGCCTGCCGAGAAACTCTCCCCTAACCCACCCAA
CCTCACCAAGAAGATGAAGAAGATTGTGGATGCCGTGATCAAGTACAAGGACAGCAGTGGACGTCAGCTCAGCGAGGTCTTCATCCAGCT
GCCCTCGCGAAAGGAGCTGCCCGAGTACTACGAGCTCATCCGCAAGCCCGTGGACTTCAAGAAGATAAAGGAGCGCATTCGCAACCACAA
GTACCGCAGCCTCAACGACCTAGAGAAGGACGTCATGCTCCTGTGCCAGAACGCACAGACCTTCAACCTGGAGGGCTCCCTGATCTATGA
AGACTCCATCGTCTTGCAGTCGGTCTTCACCAGCGTGCGGCAGAAAATCGAGAAGGAGGATGACAGTGAAGGCGAGGAGAGTGAGGAGGA
GGAAGAGGGCGAGGAGGAAGGCTCCGAATCCGAATCTCGGTCCGTCAAAGTGAAGATCAAGCTTGGCCGGAAGGAGAAGGCACAGGACCG
GCTGAAGGGCGGCCGGCGGCGGCCGAGCCGAGGGTCCCGAGCCAAGCCGGTCGTGAGTGACGATGACAGTGAGGAGGAACAAGAGGAGGA
CCGCTCAGGAAGTGGCAGCGAAGAAGACTGAGCCCCGACATTCCAGTCTCGACCCCGAGCCCCTCGTTCCAGAGCTGAGATGGCATAGGC
CTTAGCAGTAACGGGTAGCAGCAGATGTAGTTTCAGACTTGGAGTAAAACTGTATAAACAAAAGAATCTTCCATATTTATACAGCAGAGA
AGCTGTAGGACTGTTTGTGACTGGCCCTGTCCTGGCATCAGTAGCATCTGTAACAGCATTAACTGTCTTAAAGAGAGAGAGAGAGAATTC
CGAATTGGGGAACACACGATACCTGTTTTTCTTTTCCGTTGCTGGCAGTACTGTTGCGCCGCAGTTTGGAGTCACTGTAGTTAAGTGTGG
ATGCATGTGCGTCACCGTCCACTCCTCCTACTGTATTTTATTGGACAGGTCAGACTCGCCGGGGGCCCGGCGAGGGTATGTCAGTGTCAC

>In-frame_ENST00000309311_ENST00000450717_TCGA-K1-A3PO-11A_EEF2_chr19_3982805_-_SMARCA4_chr19_11151983_length(amino acids)=330AA_start in transcript=478_stop in transcript=1470
MRVRRVRADGDSAAAGHCRAHQACADDEQDGPRPAGAAAGARGALPDFPAHRGERERHHLHLRRGRERPHGQHHAIEEGTLEEIEEEVRQ
KKSSRKRKRDSDAGSSTPTTSTRSRDKDDESKKQKKRGRPPAEKLSPNPPNLTKKMKKIVDAVIKYKDSSGRQLSEVFIQLPSRKELPEY
YELIRKPVDFKKIKERIRNHKYRSLNDLEKDVMLLCQNAQTFNLEGSLIYEDSIVLQSVFTSVRQKIEKEDDSEGEESEEEEEGEEEGSE

--------------------------------------------------------------

Top

Fusion Gene PPI Analysis for EEF2-SMARCA4


check button Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in

ChiPPI page.


check button Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160)
HgeneHgene's interactorsTgeneTgene's interactors


check button - Retained PPIs in in-frame fusion.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenStill interaction with


check button - Lost PPIs in in-frame fusion.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenInteraction lost with


check button - Retained PPIs, but lost function due to frame-shift fusion.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenInteraction lost with


Top

Related Drugs for EEF2-SMARCA4


check button Drugs targeting genes involved in this fusion gene.
(DrugBank Version 5.1.8 2021-05-08)
PartnerGeneUniProtAccDrugBank IDDrug nameDrug activityDrug typeDrug status
HgeneEEF2P13639DB11823EsketamineInhibitorSmall moleculeApproved|Investigational
HgeneEEF2P13639DB11823EsketamineInhibitorSmall moleculeApproved|Investigational
HgeneEEF2P13639DB12688Moxetumomab PasudotoxInactivatorBiotechApproved|Investigational
HgeneEEF2P13639DB12688Moxetumomab PasudotoxInactivatorBiotechApproved|Investigational

Top

Related Diseases for EEF2-SMARCA4


check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource
HgeneEEF2C0001418Adenocarcinoma1CTD_human
HgeneEEF2C0006142Malignant neoplasm of breast1CTD_human
HgeneEEF2C0007134Renal Cell Carcinoma1CTD_human
HgeneEEF2C0024121Lung Neoplasms1CTD_human
HgeneEEF2C0027626Neoplasm Invasiveness1CTD_human
HgeneEEF2C0027627Neoplasm Metastasis1CTD_human
HgeneEEF2C0029408Degenerative polyarthritis1CTD_human
HgeneEEF2C0086743Osteoarthrosis Deformans1CTD_human
HgeneEEF2C0205641Adenocarcinoma, Basal Cell1CTD_human
HgeneEEF2C0205642Adenocarcinoma, Oxyphilic1CTD_human
HgeneEEF2C0205643Carcinoma, Cribriform1CTD_human
HgeneEEF2C0205644Carcinoma, Granular Cell1CTD_human
HgeneEEF2C0205645Adenocarcinoma, Tubular1CTD_human
HgeneEEF2C0242379Malignant neoplasm of lung1CTD_human
HgeneEEF2C0279702Conventional (Clear Cell) Renal Cell Carcinoma1CTD_human
HgeneEEF2C0678222Breast Carcinoma1CTD_human
HgeneEEF2C1257931Mammary Neoplasms, Human1CTD_human
HgeneEEF2C1266042Chromophobe Renal Cell Carcinoma1CTD_human
HgeneEEF2C1266043Sarcomatoid Renal Cell Carcinoma1CTD_human
HgeneEEF2C1266044Collecting Duct Carcinoma of the Kidney1CTD_human
HgeneEEF2C1306837Papillary Renal Cell Carcinoma1CTD_human
HgeneEEF2C1458155Mammary Neoplasms1CTD_human
HgeneEEF2C1836395SPINOCEREBELLAR ATAXIA 261CTD_human;ORPHANET;UNIPROT
HgeneEEF2C4704874Mammary Carcinoma, Human1CTD_human
TgeneSMARCA4C2750074Rhabdoid Tumor Predisposition Syndrome 27CLINGEN;CTD_human;GENOMICS_ENGLAND
TgeneSMARCA4C0262584Carcinoma, Small Cell4CTD_human
TgeneSMARCA4C0919267ovarian neoplasm4CGI;CTD_human
TgeneSMARCA4C1140680Malignant neoplasm of ovary4CGI;CTD_human
TgeneSMARCA4C0009405Hereditary Nonpolyposis Colorectal Neoplasms2CLINGEN
TgeneSMARCA4C1112155Hereditary non-polyposis colorectal cancer syndrome2CLINGEN
TgeneSMARCA4C1333990Hereditary Nonpolyposis Colorectal Cancer2CLINGEN
TgeneSMARCA4C1333991Hereditary Non-Polyposis Colon Cancer Type 22CLINGEN
TgeneSMARCA4C2936783Colorectal cancer, hereditary nonpolyposis, type 12CLINGEN
TgeneSMARCA4C2985524Rhabdoid tumor predisposition syndrome2ORPHANET
TgeneSMARCA4C0006413Burkitt Lymphoma1CTD_human
TgeneSMARCA4C0009171Cocaine Abuse1CTD_human
TgeneSMARCA4C0036920Sezary Syndrome1CTD_human
TgeneSMARCA4C0039981Thoracic Neoplasms1CTD_human
TgeneSMARCA4C0149925Small cell carcinoma of lung1CTD_human
TgeneSMARCA4C0205944Sarcoma, Epithelioid1CTD_human
TgeneSMARCA4C0205945Sarcoma, Spindle Cell1CTD_human
TgeneSMARCA4C0236736Cocaine-Related Disorders1CTD_human
TgeneSMARCA4C0265338Coffin-Siris syndrome1CTD_human;GENOMICS_ENGLAND
TgeneSMARCA4C0343640African Burkitt's lymphoma1CTD_human
TgeneSMARCA4C0600427Cocaine Dependence1CTD_human
TgeneSMARCA4C1261473Sarcoma1CTD_human
TgeneSMARCA4C1961099Precursor T-Cell Lymphoblastic Leukemia-Lymphoma1CTD_human
TgeneSMARCA4C2239246Endometrial stromal sarcoma, high grade1GENOMICS_ENGLAND
TgeneSMARCA4C3281201MENTAL RETARDATION, AUTOSOMAL DOMINANT 121GENOMICS_ENGLAND
TgeneSMARCA4C3553249COFFIN-SIRIS SYNDROME 41GENOMICS_ENGLAND;UNIPROT
TgeneSMARCA4C4721444Burkitt Leukemia1CTD_human